Monitoring the Interfacial Behavior of Selective Y5 Receptor Antagonist on Colloidal Gold Nanoparticle Surfaces: Surface-Enhanced Vibrational Spectroscopy Studies
Source abstract
Abstract
This report describes the first detailed characterization of the molecular structure of Lu AA33810, a selective Y5 receptor antagonist, and its behavior at the solid/liquid interface after conjugation with gold nanoparticles (GNPs). Physicochemical characterization, including imaging by scanning electron microscopy as well as electrophoretic mobility and dynamic light scattering measurements, was performed to determine the morphology, electrokinetic properties and range of stability of the GNPs. A comprehensive vibrational analysis, employing Raman spectroscopy, Fourier transform infrared absorption, surface-enhanced Raman spectroscopy, and surface-enhanced infrared absorption methods, is reported. The experimental data are supported by density functional theory calculations. It is implied that the Thz and Phe rings determine the adsorption geometry of Lu AA33810 on the studied GNPs and adopt a tilted orientation, exposing the interaction between the Thz free electron pair and the metallic nanosubstrates. The analysis also provides evidence for strong interaction between the free electron pairs located on the oxygen atoms of the SO 2 fragment of methanesulfonamide and the GNPs. The results provide important insight into designing new compounds with agonistic or antagonistic properties toward the Y5 receptor.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrochemical Analysis and Applications · Spectroscopy and Quantum Chemical Studies · Mass Spectrometry Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Nuclear Physics Polish Academy of Sciences, PL-31342 Krakow, Poland
J. Haber Institute of Catalysis and Surface Chemistry Polish Academy of Sciences, PL-30239 Krakow, Poland
Institute of Pharmacology, Polish Academy of Sciences, Department of Neurobiology, 31-343 Krakow, Smetna Street 12, Poland
Funding
Ministerstwo Nauki i Szkolnictwa Wyzszego
References (71)
Show source-provided references
1. 10.1016/0306-4522(85)90260-X10.1016/0306-4522(85)90260-X ↗
2. 10.1016/0024-3205(86)90061-510.1016/0024-3205(86)90061-5 ↗
3. 10.1016/0301-0082(92)90038-G10.1016/0301-0082(92)90038-G ↗
4. 10.1016/0163-7258(95)98598-K10.1016/0163-7258(95)98598-K ↗
5. 10.1016/S0165-0173(97)00052-010.1016/S0165-0173(97)00052-0 ↗
6. 10.2174/15748890677877368910.2174/157488906778773689 ↗
7. 10.1016/j.pharmthera.2011.03.01110.1016/j.pharmthera.2011.03.011 ↗
8. 10.1016/j.expneurol.2012.09.00410.1016/j.expneurol.2012.09.004 ↗
9. 10.1093/rb/rbv01310.1093/rb/rbv013 ↗
10. 10.1016/j.nbd.2016.07.02210.1016/j.nbd.2016.07.022 ↗
11. 10.1016/S0166-2236(96)01057-010.1016/S0166-2236(96)01057-0 ↗
12. Michel M. C. · Pharmacol. Rev. · 1998 · 50 · 14310.1016/S0031-6997(24)01352-8 ↗
13. 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E ↗
14. 10.1016/0165-6147(91)90610-510.1016/0165-6147(91)90610-5 ↗
15. 10.1016/j.bmcl.2012.11.00510.1016/j.bmcl.2012.11.005 ↗
16. 10.2174/138955751466614102923381610.2174/1389557514666141029233816 ↗
17. 10.1002/emmm.20100010010.1002/emmm.201000100 ↗
18. 10.1124/jpet.108.14463410.1124/jpet.108.144634 ↗
19. 10.1016/j.bmcl.2011.06.12410.1016/j.bmcl.2011.06.124 ↗
20. 10.1007/s00213-016-4495-310.1007/s00213-016-4495-3 ↗
21. Osawa M. · 2001
22. 10.1039/C5NR01654A10.1039/C5NR01654A ↗
23. 10.1021/cr068107d10.1021/cr068107d ↗
24. 10.1021/nn800569f10.1021/nn800569f ↗
25. 10.1016/j.saa.2014.03.06210.1016/j.saa.2014.03.062 ↗
26. 10.1186/1743-8977-2-810.1186/1743-8977-2-8 ↗
27. Smith E. · 2005
28. Baia M. · 200810.1007/978-3-540-78283-4 ↗
29. 10.1366/000370204247542010.1366/0003702042475420 ↗
30. 10.1021/jp102735510.1021/jp1027355 ↗
31. 10.1366/000370294402977610.1366/0003702944029776 ↗
32. 10.1016/j.apsusc.2017.01.27010.1016/j.apsusc.2017.01.270 ↗
33. 10.1002/jrs.450510.1002/jrs.4505 ↗
34. 10.1016/j.jcis.2014.09.05310.1016/j.jcis.2014.09.053 ↗
35. 10.1063/1.44444210.1063/1.444442 ↗
36. 10.1016/0039-6028(83)90345-X10.1016/0039-6028(83)90345-X ↗
37. Frisch M. J. · 2003
38. Jensen F. · 2007
39. 10.1016/j.molstruc.2014.05.06610.1016/j.molstruc.2014.05.066 ↗
40. 10.1016/j.molstruc.2010.08.03010.1016/j.molstruc.2010.08.030 ↗
41. 10.1080/00958972.2011.56094010.1080/00958972.2011.560940 ↗
42. 10.1016/j.cplett.2004.12.09610.1016/j.cplett.2004.12.096 ↗
43. O’Boyle N. M. · 2004
44. 10.1002/jhet.151910.1002/jhet.1519 ↗
45. 10.1016/j.molstruc.2013.07.01910.1016/j.molstruc.2013.07.019 ↗
46. 10.1039/C4CE01650E10.1039/C4CE01650E ↗
47. 10.1135/cccc1989002810.1135/cccc19890028 ↗
48. 10.1016/S0924-2031(98)00085-X10.1016/S0924-2031(98)00085-X ↗
49. 10.1021/bi981477e10.1021/bi981477e ↗
50. 10.1021/jp073752p10.1021/jp073752p ↗
51. 10.1016/j.saa.2012.01.06510.1016/j.saa.2012.01.065 ↗
52. 10.1016/j.molstruc.2010.01.03310.1016/j.molstruc.2010.01.033 ↗
53. 10.1016/0584-8539(75)80176-010.1016/0584-8539(75)80176-0 ↗
54. 10.1021/jo00797a01310.1021/jo00797a013 ↗
55. 10.1021/j100269a03110.1021/j100269a031 ↗
56. 10.1021/jp503392e10.1021/jp503392e ↗
57. 10.1007/s00216-006-1071-410.1007/s00216-006-1071-4 ↗
58. 10.1366/000370293406747810.1366/0003702934067478 ↗
59. 10.1021/la00040a03310.1021/la00040a033 ↗
60. 10.1021/acs.analchem.5b0413110.1021/acs.analchem.5b04131 ↗
61. 10.1007/3-540-44552-8_910.1007/3-540-44552-8_9 ↗
62. 10.1021/jp800167v10.1021/jp800167v ↗
63. 10.1103/PhysRev.45.70610.1103/PhysRev.45.706 ↗
64. 10.1038/nsb95410.1038/nsb954 ↗
65. 10.1016/0009-3084(91)90077-O10.1016/0009-3084(91)90077-O ↗
66. 10.1021/bi00204a02910.1021/bi00204a029 ↗
67. 10.1021/bi00544a00710.1021/bi00544a007 ↗
68. 10.1016/j.apsusc.2015.02.04810.1016/j.apsusc.2015.02.048 ↗
69. 10.1021/jp953712y10.1021/jp953712y ↗
70. 10.1016/S0021-9797(03)00257-110.1016/S0021-9797(03)00257-1 ↗
71. Schaumann E. · 2014